MarketPeel
Pricing
…
Chief Business Officer
Andrew Hollman Meyer
Tue, Jan 3, 2023
Jan 3
received an award in JANX
90,000 shares @ $0.00
New position
JANXJanux Therapeutics, Inc.
HealthcareBiotechnology
1D0.00%
1W+6.95%
1M+13.44%
3M+20.76%
6M—
1Y—

Recent insider activity at JANX

Jun 2Janeen Noel DoyleSold$56.94kMay 11Maria DobekSold$28.88kJan 2David Alan CampbellSold$110.83kJan 2Maria DobekSold$20.07kJan 2Andrew Hollman MeyerSold$25.80kJan 2Thomas DiraimondoSold$34.39kJan 2Charles M. WinterSold$32.97kJan 2Zachariah MciverSold$37.26k
Full JANX profile →Andrew Hollman Meyer’s trading history →
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback